GHK-Cu / BPC-157 / Thymosin β4 / KPV
Research use only. For laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic or medical device.
Unit pricing
Specification
| Name | GHK-Cu / BPC-157 / Thymosin β4 / KPV |
|---|---|
| Synonyms | Lyophilised blend: GHK-Cu 50 mg + BPC-157 10 mg + Thymosin β4 (TB-500) 10 mg + KPV 10 mg |
| GHK-Cu, 50 mg | CAS 89030-95-5 |
| BPC-157, 10 mg | CAS 137525-51-0 |
| Thymosin β4 (TB-500), 10 mg | CAS 77591-33-4 |
| KPV, 10 mg | CAS 67727-97-3 |
| Quantity per vial | 80 mg |
| Form | Lyophilised powder, requires reconstitution |
| Storage | -20 °C, desiccated, protected from light |
Description
Multi-component lyophilised preparation. GHK-Cu: Copper(II) complex of the tripeptide Gly-His-Lys. High-affinity Cu2+ chelation through the His imidazole and Gly amino nitrogens. BPC-157: Synthetic pentadecapeptide (GEPPPGKPADDAGLV) derived from a partial sequence of gastric body protection compound. Thymosin β4 (TB-500): 43-residue N-acetylated peptide. The central LKKTETQ motif sequesters G-actin and regulates actin polymerisation. KPV: C-terminal tripeptide of α-MSH. Studied for NF-κB pathway interactions via PepT1-mediated uptake.
Supplied as a lyophilised powder in a sealed glass vial. Requires reconstitution in an appropriate solvent prior to use. Store at -20 °C, desiccated and protected from light.